Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-913-4 | CAS number: 111-84-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: inhalation
Administrative data
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Basic data given.
Cross-reference
- Reason / purpose for cross-reference:
- reference to same study
Data source
Reference
- Reference Type:
- publication
- Title:
- Toxicity of n-C9 to n-C13 alkanes in the rat on short term inhalation.
- Author:
- Nilsen, O.G et al.
- Year:
- 1 988
- Bibliographic source:
- Pharmacology & Toxicology 62:259-266
Materials and methods
- Principles of method if other than guideline:
- Ten male Sprague-Dawley rats per concentration were exposed to nonane via inhalation at 2414, 3560, 4438, or 5280 ppm for 8 hours.
- GLP compliance:
- not specified
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- Nonane
- EC Number:
- 203-913-4
- EC Name:
- Nonane
- Cas Number:
- 111-84-2
- Molecular formula:
- C9H20
- IUPAC Name:
- nonane
- Details on test material:
- - Name of test material (as cited in study report): n-nonane (Fluka)
- Analytical purity: 99.89% (GC); quoted purity: >99%
- Cat. no.: 74525
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Mollegaard A/S, Ll. Skensved, Denmark
- Weight at exposure: 200 g ± 20 %
- Housing: The number of animals in each cage was 4 with a maximum of 4 cages in each inhalation chamber.
- Individual metabolism cages: no
- Diet (e.g. ad libitum): ad libitium except during exposure
- Water (e.g. ad libitum): ad libitium except during exposure
- Acclimation period: 4 to 6 days before the start of exposure
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22±1
- Humidity (%): 40-70
- Photoperiod (hrs dark / hrs light): 10/14
Administration / exposure
- Route of administration:
- inhalation: vapour
- Type of inhalation exposure:
- whole body
- Vehicle:
- other: unchanged (no vehicle)
- Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: Animals were kept in conically shaped 0.7 cubic metre steel chambers with glass front and walls.
- Method of holding animals in test chamber: a maximum number of 18 animals in each chamber
- System of generating particulates/aerosols: Dynamic exposure was performed by passing high oil-and dust-filtered air under pressure through 4 reservoirs of each containing 0.5 L of the test substance. At an air flow rate of 30-40 L/min an outlet concentration equal to 95% of vapour saturation was achieved. The vapour generating system was located in a water bath. Saturation concentrations of nonane at 20°C were achieved by keeping a constant temperature in the water bath of 22.5°C.
Air from the vapour generating system was introduced at the top of the exposure chamber and drained from the chamber through a perforated bottom outlet.
- Temperature, humidity, pressure in air chamber: 22±1 °C, 40-70%
Air was withdrawn from the inhalation chamber by a ventilation fan creating a negative pressure of 2-5 mm H2O on the inside of the chamber. During exposure the flow of air through the chamber (exposure and control) was 30-40 L/min, corresponding approx. to 3 air changes/hour.
TEST ATMOSPHERE
- Brief description of analytical method used:
Concentration of nonane in the inhalation chamber was monitored automatically every 15 min by on-line gas chromatography. Nonane was detected by a FID detector and quantified by a programmable integrator (Shimadzu C-R3A) which also controlled the frequency and sequence of air sampling. - Analytical verification of test atmosphere concentrations:
- yes
- Duration of exposure:
- 8 h
- Concentrations:
- 2414; 3560; 4438; 5280 ppm (corresponding to approx. 12.84; 18.94; 23.61; 28.09 mg/L)
- No. of animals per sex per dose:
- 10
- Control animals:
- yes
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations: During inhalation all animals were observed at 15 and 30 min. intervals. For the first 8 hours after exposure all animals were observed at hourly, then at 2 hours intervals during daytime for 14 consecutive days.
- Necropsy of survivors performed: yes
- Other examinations performed: All animals were subjected to complete necropsy which included examination of the external surface of the body, all orifices, and the cranial, thoracic and abdominal cavities and their contents according to the OECD procedures (OECD 1987). In addition to general activity, acute effects as coordination difficulties, tremor, spasms and lethality were monitored. - Statistics:
- Calculations were performed according to the method described by Finney (1964).
Results and discussion
- Preliminary study:
- not applicable
Effect levels
- Key result
- Sex:
- male
- Dose descriptor:
- LC50
- Effect level:
- ca. 23.76 mg/L air
- Exp. duration:
- 8 h
- Remarks on result:
- other: LC50= 4467±189 ppm
- Mortality:
- 0/10 (2414 ppm)
1/10 (3560 ppm)
4/10 (4438 ppm)
9/10 (5280 ppm)
Death occured after 4 hours in the group exposed to 5280 ppm. The length of time before the appearance of death increased in proportion with the decrease of n-nonane concentration in the inhaled air. - Clinical signs:
- other: Specific symptoms as tremor, spasms and limb paralysis were observed in animals exposed to nonane in the range from 5280 to 3560 ppm. Specific symptoms occured after 2 hours in the group exposed to 5280 ppm. The length of time before the appearance of spe
- Body weight:
- All rats exposed to n-nonane showed body weight slightly lower (about 10%) than the control groups. Weight curves indicated the difference to be due to an initial lag in the gain of weight during the 3 first days of observation. From day 3 to 14 the increase in weight was equal for exposed and control animals. However, the difference in total weight persisted throughout the observation.
- Gross pathology:
- No morphological alterations were observed in heart or kidneys or brain.
- Other findings:
- - Organ weights:
No significant differences in the weight of the heart, kidneys, liver or brain were found in the 4438 ppm test group (see table 2).
- Histopathology:
Liver:
Microscopically, dilatation of the sinusoids were found in all four animals dying during exposure to 4438 ppm nonane, and 3 of these animals also showed definite though slight fatty changes of the liver cells. In animals surviving exposure or among the controls no such changes were found. Occasionally, single necrotic hepatocytes were encountered in animals both form the experimental groups and among the controls.
Lungs:
The total weight of the lungs in 2 of the animals dying during exposure was approx. twice the weight of the control animals 2.86 g and 2.88 g, compared to 1.26 g. Microscopically, 3 animals showed marked pulmonary oedema. These animals died during exposure and in 2 of them the pulmonary weight was also increased. All exposed animals showed a blue discolouration of the skin during exposure, giving the impression of peripheral cyanosis, and thus cardiopulmonary insufficiency.
Brain:
No macroscopical abnormalities were recorded. In exposed animals which died during exposure, no pathological changes were found. Among the 6 surviving animals, 1 animal showed a few severely damaged neurons of the hippocampus. After 14 days after exposure, extensive changes were observed including rarification of Purkinje cells (cerebellar cortex) and in some instances also a high number of severely damaged neurons were observed in the surviving animals. These changes apparently were not entirely random but seemed to some extent to be segmental. In areas showing massive loss of Purkinje cells there was no obvious glial reaction.
Morphometry of the cerebellum:
The results demonstrated a loss of Purkinje cells in the animals which survived exposure. This is reflected by a reduced density of Purkinje cell profiles along the line which defines the Purkinje cell layer. The reduced density of the visible transections is only in part explained by a reduction of the cellsize, as there is also a significantly reduced number of Purkinje cells per unit area of Purkinje cell layer. The results also indicate a reduction of tissue volume in the other layers of the cerebellum as there was decrease in cerebellar volume relative to the extent of the Purkinje cell layer. There was no clear-cut change of the volume distribution between the different layers. There was no detectable difference between the animals which died during exposure and the controls.
- Other observations:
All animals surviving the 8 hours exposure seemed to recover from their specific symptoms during the entire observation period. The time needed for an apparent full recovery was in proportion with the concentration of n-nonane to which the animal had been exposed. The apparent full recovery time was 7 days for the 5280 ppm group (1 animal), 5 days for the 4438 ppm group (6 animals), 1 day for the 3560 ppm group (9 animals) and 0 -4 hours for the 2414 ppm group (10 animals).
Any other information on results incl. tables
In general, no toxic effects were observed in animals exposed to 2414 ppm of nonane.
Table 1: Concentration of nonane in inhaled air.
A period of 1 hour was needed to achieve steady state air concentration.
chamber concentration [ppm ± SD] (measured at 15 min intervals; generated at 22.5°C) |
5280 ± 77* |
4438 ± 319* |
3560 ± 17 |
2414 ± 7 |
* saturation level
Table 2: mean total body weights and organs weights [g ± SD] of rats exposed to 4438 ppm nonane
|
No. |
Total bw |
Brain |
Lungs |
Heart |
Liver |
Kidney |
Dead animals |
4 |
178.8±11.2 |
1.81±0.03 |
2.05±0.95 |
1.00±0.09 |
9.93±0.82 |
2.06±0.18 |
Surviving animals |
6 |
274.8±25.2 |
1.87±0.04 |
1.41±0.11 |
1.19±0.22 |
11.88±1.52 |
2.22±0.18 |
Control animals |
3 |
201.7±12.6 |
1.85±0.09 |
1.26±0.17 |
1.03±0.15 |
9.85±0.74 |
1.87±0.10 |
Applicant's summary and conclusion
- Interpretation of results:
- other: Not classified
- Remarks:
- Criteria used for interpretation of results: other: CLP
- Conclusions:
- Under the conditions of this study, the test substance is not classified.
- Executive summary:
Under the conditions of this study, the test substance is not classified.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.